Urologix (Urologix) Debt-to-EBITDA : -27.77 (As of Mar. 2015)

Urologix Debt-to-EBITDA Chart

Urologix Annual Data
	Trend	Jun05	Jun06	Jun07	Jun08	Jun09	Jun10	Jun11	Jun12	Jun13	Jun14
Debt-to-EBITDA		Get a 7-Day Free Trial					-	-	-	-1.38	-1.56

Urologix Quarterly Data
	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15
Debt-to-EBITDA	Get a 7-Day Free Trial															-1.01	-3.95	-12.12	-63.49	-27.77

Competitive Comparison of Urologix's Debt-to-EBITDA

For the Medical Devices subindustry, Urologix's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Urologix's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Urologix's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Urologix's Debt-to-EBITDA falls into.

Urologix Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Urologix's Debt-to-EBITDA for the fiscal year that ended in Jun. 2014 is calculated as

Urologix's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2015 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2015) EBITDA data.

Urologix  (OTCPK:ULGX) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Urologix Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Urologix's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Urologix (Urologix) Business Description